NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
01/28/2025
Back to search
Official data from USPTO
LA JOLLA PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
40
Latest update
01/28/2025
Trademark type
Combined
Nice classes
5
Filing date
01/25/2017
Registration date
09/11/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/28/2025
Last transaction
01/28/2025
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/05/2018
First use in commerce
02/05/2018
Drawing code
3
Owner type
03
Owner location
Waltham, MA
Examiner
MULLEN, MARK
Current location
Historical data usage
Mark description
The mark consists of a circle split into two vertically with a wavy line of negative space, followed by the wording "La Jolla Pharmaceutical". The left hemisphere of the circle has a stylized lick of flame facing downward, while the right hemisphere has a stylized lick of flame facing upward; together, the curved lines suggest a flame facing both upward and downward. To the right of the circle is the wording "La Jolla Pharmaceutical", with "La Jolla" in large font on top and "Pharmaceutical" in smaller font below.
Holders and representatives
Holders
LA JOLLA PHARMACEUTICAL COMPANY
LA JOLLA PHARMACEUTICAL COMPANY
Representatives
Nicole Kinsley, Esq. FOLEY HOAG LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
House mark for pharmaceutical products for human usepharmaceuticals for the treatment of hypotension and antihypotensive agents
Publications
History of USPTO decisions and trademark events.
40 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
01/28/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/28/2025
E815
TEAS SECTION 8 & 15 RECEIVED
09/10/2024
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
07/22/2024
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
09/11/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
09/11/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
08/07/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/06/2018
DMCC
DATA MODIFICATION COMPLETED
08/04/2018
ALIE
ASSIGNED TO LIE
08/03/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/17/2018
CORV
REVIEW OF CORRESPONDENCE COMPLETE
07/17/2018
IUAF
USE AMENDMENT FILED
05/10/2018
EISU
TEAS STATEMENT OF USE RECEIVED
05/10/2018
EPPA
TEAS POST PUBLICATION AMENDMENT RECEIVED
05/10/2018
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/04/2018
EX1G
SOU EXTENSION 1 GRANTED
05/03/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/30/2018
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/19/2018
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
04/19/2018
NREV
NOTICE OF REVIVAL - E-MAILED
04/12/2018
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
04/11/2018
PETG
PETITION TO REVIVE-GRANTED
04/11/2018
PROA
TEAS PETITION TO REVIVE RECEIVED
04/11/2018
EXT1
SOU EXTENSION 1 FILED
03/26/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
09/26/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/01/2017
PUBO
PUBLISHED FOR OPPOSITION
08/01/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/12/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/22/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/21/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/20/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/20/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
04/26/2017
GNRT
NON-FINAL ACTION E-MAILED
04/26/2017
CNRT
NON-FINAL ACTION WRITTEN
04/26/2017
DOCK
ASSIGNED TO EXAMINER
04/20/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/28/2017
NWAP
NEW APPLICATION ENTERED
01/28/2017
Continuous trademark protection
Get notified about every new filing that threatens LA JOLLA PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.